All manufacturing activities at Indian Pharma company Marion Biotech Pvt Ltd have been stopped following allegations by Uzbekistan that at least 18 children died in the country after consuming the medicine.
The manufacturing activities have been stopped after the inspection by the Central Drugs Standard Control Organisation (CDSCO). A joint inspection of the manufacturer’s Noida facility was carried out by the teams of the Uttar Pradesh Drug Control Department and CDSCO.
“Following inspection by @CDSCO_INDIA_INF team in view of reports of contamination in cough syrup Dok1 Max, all manufacturing activities of Marion Biotech at NOIDA unit have been stopped yesterday night, while further investigation is ongoing”, said Union Health Minister Mansukh Mandaviya in a tweet on Friday.
However, the further investigation is in progress by the government agencies. The samples of the cough syrup have been taken from the manufacturing premises and sent to Regional Drugs Testing Laboratory (RDTL), Chandigarh for testing.
Kailash IVF, the fertility centre under Kailash Healthcare, has completed asuccessful year of providing advanced,…
SS Innovations International, the maker of India’s first and only home-grown surgical robotic system, SSI…
An Ayurvedic preventive wellness brand - Amma Living – has made its entry into India’s…
In an effort to promote early detection and prevention of deadly cancer among court staffs,…
Nearly 90 per cent of glaucoma cases in India remain undiagnosed, experts warned at a…
The All India Institute of Medical Sciences on Wednesday flagged concern over a spurt in…